Literature DB >> 25227426

Successful transfemoral Edwards SAPIEN 3 valve in valve implantation in a patient with a degenerated aortic bioprosthesis associated with severe paravalvular aortic regurgitation.

Klaudija Bijuklic1, Lorenz Hansen, Julian Witt, Joachim Schofer.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25227426     DOI： 10.1007/s00392-014-0760-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  4 in total

1.  Interventional options for severe aortic regurgitation after transcatheter aortic valve implantation: balloons, snares, valve-in-valve.

Authors:  Holger Eggebrecht; Mirko Doss; Axel Schmermund; Bernd Nowak; Josef Krissel; Thomas Voigtländer
Journal:  Clin Res Cardiol       Date:  2012-04-03       Impact factor: 5.460

2.  Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access.

Authors:  Martin Greif; Philipp Lange; Helmut Mair; Christoph Becker; Christoph Schmitz; Gerhard Steinbeck; Christian Kupatt
Journal:  Clin Res Cardiol       Date:  2012-06-23       Impact factor: 5.460

Review 3.  Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature.

Authors:  Krys Milburn; Vinayak Bapat; Martyn Thomas
Journal:  Clin Res Cardiol       Date:  2014-01-21       Impact factor: 5.460

4.  Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience.

Authors:  Patrick Diemert; Philipp Lange; Martin Greif; Moritz Seiffert; Lenard Conradi; Steffen Massberg; Stefan Blankenberg; Hermann Reichenspurner; Christian Hagl; Christoph Schmitz; Holger Schröfel; Hendrik Treede; Gerhard Schymik; Christian Kupatt
Journal:  Clin Res Cardiol       Date:  2013-11-20       Impact factor: 5.460
  4 in total
  1 in total

1.  Antegrade transcatheter mitral valve-in-valve implantation with combined atrial septal defect closure.

Authors:  Felipe C Fuchs; Christoph Hammerstingl; Jan-Malte Sinning; Fritz Mellert; Nikos Werner; Eberhard Grube; Georg Nickenig
Journal:  Clin Res Cardiol       Date:  2015-11-09       Impact factor: 5.460
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.